TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 14627847

Group type: EXPERIMENTAL
Intervention: FDG dual-head coincidence gamma camera imaging (DHC)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Fluorodeoxyglucose positron emission tomography (FDG PET)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Traditional staging
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: FDG PET
Number of subjects: 42
Study: 10878691

Group type: EXPERIMENTAL
Intervention: Hypertensive patients
Number of subjects: 30

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 30
Study: 8937620

Group type: EXPERIMENTAL
Intervention: Fluoxetine (40 mg)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 1554660

Group type: EXPERIMENTAL
Intervention: PGE2 gel (2 mg) instilled into the posterior fornix, with a further dose of 1 mg if contractions did not commence after 6 hours
Number of subjects: 230

Group type: COMPARATOR
Intervention: Conservative management (observation for up to 24 hours)
Number of subjects: 230
Study: 3884767

Group type: EXPERIMENTAL
Intervention: Tetracycline (TTC) with freeze-dried bone allografts (FDBA)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Tetracycline (TTC) plus debridement only
Number of subjects: 16

Group type: COMPARATOR
Intervention: Freeze-dried bone allografts (FDBA) alone
Number of subjects: 16

Group type: COMPARATOR
Intervention: Debridement only
Number of subjects: 16
Study: 29331848

Group type: EXPERIMENTAL
Intervention: Repetitive transcranial magnetic stimulation (rTMS)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 9
Study: 27136412

Group type: EXPERIMENTAL
Intervention: High-dose aerobic exercise
Number of subjects: 0

Group type: COMPARATOR
Intervention: Aerobic exercise (general)
Number of subjects: 0
Study: 23945965

Group type: EXPERIMENTAL
Intervention: Nifedipine controlled-release 40 mg b.i.d.
Number of subjects: 325

Group type: COMPARATOR
Intervention: Nifedipine controlled-release 40 mg q.d.
Number of subjects: 325
Study: 21541696

Group type: EXPERIMENTAL
Intervention: Online cognitive behavioural therapy (CBT)
Number of subjects: 297

Group type: COMPARATOR
Intervention: Waiting list control
Number of subjects: 297
Study: 20487589

Group type: EXPERIMENTAL
Intervention: 48 g/d WG cereal (WGM)
Number of subjects: 32

Group type: COMPARATOR
Intervention: 48 g placebo cereal (non‐whole grain (NWG))
Number of subjects: 32
Study: 17321105

Group type: EXPERIMENTAL
Intervention: Exposure plus internal distraction
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Exposure plus external distraction
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Exposure plus internal focus
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Exposure plus external focus
Number of subjects: 50

Group type: COMPARATOR
Intervention: Exposure alone
Number of subjects: 50
Study: 15692967

Group type: EXPERIMENTAL
Intervention: Oral cyclophosphamide for treatment of SSc-associated interstitial lung disease
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: SF-36
Number of subjects: 138
Study: 11845217

Group type: EXPERIMENTAL
Intervention: Virtual reality (VR) glasses during lumbar punctures
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard intervention during lumbar punctures (control group)
Number of subjects: 30
Study: 10075141

Group type: EXPERIMENTAL
Intervention: Nicorandil 20 mg twice daily
Number of subjects: 188

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 188
Study: 7734095

Group type: EXPERIMENTAL
Intervention: Captopril (25 mg twice daily for 1 week)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 2187912

Group type: EXPERIMENTAL
Intervention: Alprazolam
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 79

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 79
Study: 7009264

Group type: EXPERIMENTAL
Intervention: Mixed meals (20, 40, and 60 g of complex carbohydrate)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Dextrose (20, 40, and 60 g)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 24
Study: 30863463

Group type: EXPERIMENTAL
Intervention: Group seizure first aid training intervention
Number of subjects: 53
Study: 28955715

Group type: EXPERIMENTAL
Intervention: siponimod 2 mg once daily (preceding treatment)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: siponimod 2 mg once daily (interrupted treatment)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: siponimod 2 mg once daily (concomitant treatment)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: siponimod 2 mg once daily (all groups)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: siponimod
Number of subjects: 120
Study: 24957785

Group type: EXPERIMENTAL
Intervention: Insulin glargine
Number of subjects: 701

Group type: COMPARATOR
Intervention: NPH insulin
Number of subjects: 701
Study: 25590448

Group type: EXPERIMENTAL
Intervention: BIPAP Group (n=20)
Number of subjects: 60

Group type: COMPARATOR
Intervention: EPAP Group (n=20)
Number of subjects: 60

Group type: COMPARATOR
Intervention: IPPB Group (n=20)
Number of subjects: 60
Study: 21069381

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy (HBOT) at 2.0 atm with inhalation of 100% oxygen for 60 min at 3, 24, and/or 48 hours after hepatectomy.
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control group (no HBOT).
Number of subjects: 41
Study: 19898575

Group type: EXPERIMENTAL
Intervention: Carotid Thrombendarterectomy (CEA)
Number of subjects: 408

Group type: EXPERIMENTAL
Intervention: Endovascular Stenting
Number of subjects: 408
Study: 16897112

Group type: EXPERIMENTAL
Intervention: Stanger bath therapy combined with amitriptyline (10 mg/day for 8 weeks)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Amitriptyline (10 mg/day for 8 weeks) alone
Number of subjects: 50
Study: 14962012

Group type: EXPERIMENTAL
Intervention: Theophylline 7 mg kg‐1
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 11274240

Group type: EXPERIMENTAL
Intervention: High-dose omega-3 fatty acids (EPA 3.76 g and DHA 2.94 g daily)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Low-dose omega-3 fatty acids (EPA 1.88 g and DHA 1.47 g daily)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Omacor-treated patients (63 patients)
Number of subjects: 73
Study: 9674329

Group type: EXPERIMENTAL
Intervention: Cefuroxime axetil suspension, 15 mg/kg, single oral dose
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 26
Study: 7517991

Group type: EXPERIMENTAL
Intervention: Hydroxyethyl starch 200,000/0.62 (HES)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Dextran 60,000
Number of subjects: 22
Study: 2694158

Group type: EXPERIMENTAL
Intervention: Beta-carotene plus canthaxanthin
Number of subjects: 11

Group type: COMPARATOR
Intervention: Beta-carotene
Number of subjects: 11
Study: 5171687

Group type: COMPARATOR
Intervention: Expressed human milk and proprietary breast-milk substitute (S26) with protein intake of not more than 4.5 g/kg/day
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Evaporated milk formula with protein intake ranging from 6.15 to 12.3 g/kg/day
Number of subjects: 5

Group type: COMPARATOR
Intervention: Normal feeds with normal protein intake
Number of subjects: 5
Study: 31672458

Group type: EXPERIMENTAL
Intervention: Sevelamer (1600 mg three times daily)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 30998694

Group type: EXPERIMENTAL
Intervention: Age similarity manipulation (students)
Number of subjects: 582

Group type: EXPERIMENTAL
Intervention: Age similarity manipulation (older adults)
Number of subjects: 582

Group type: EXPERIMENTAL
Intervention: Perceived similarity
Number of subjects: 582
Study: 28768531

Group type: EXPERIMENTAL
Intervention: Indacaterol
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Glycopyrronium
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Combination therapy (Glycopyrronium + Indacaterol)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Combination therapy
Number of subjects: 14

Group type: COMPARATOR
Intervention: Non-asthmatic control
Number of subjects: 14
Study: 25511789

Group type: EXPERIMENTAL
Intervention: Levetiracetam (LEV), 500 mg/body every 12 hours until postoperative day 7
Number of subjects: 146

Group type: COMPARATOR
Intervention: Phenytoin (PHT), 15-18 mg/kg fosphenytoin followed by 125 mg PHT every 12 hours until postoperative day 7
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Levetiracetam (LEV) in subgroup analysis (no seizures before craniotomy)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Phenytoin (PHT) in subgroup analysis (no seizures before craniotomy)
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Levetiracetam (LEV)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Phenytoin (PHT)
Number of subjects: 146
Study: 23332040

Group type: EXPERIMENTAL
Intervention: Biofortified cassava porridge with added oil (2 mg β-carotene, 15 ml peanut or rapeseed oil, 20 g total fat)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Biofortified cassava porridge without added oil (2 mg β-carotene, 6 g total fat)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Unfortified white cassava porridge with added oil (0.3 mg retinyl palmitate, 20 g total fat)
Number of subjects: 10
Study: 20629074

Group type: EXPERIMENTAL
Intervention: Submandibular salivary gland transfer procedure
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 70
Study: 19221765

Group type: EXPERIMENTAL
Intervention: Gum chewing
Number of subjects: 256

Group type: COMPARATOR
Intervention: Control/Placebo
Number of subjects: 256
Study: 17125604

Group type: EXPERIMENTAL
Intervention: PEG‐IFN alpha‐2a (n=42)
Number of subjects: 72
Study: 15177711

Group type: EXPERIMENTAL
Intervention: OCD patients
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: OCD patients with first-degree relatives with OCD
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: OCD patients with childhood onset
Number of subjects: 75

Group type: COMPARATOR
Intervention: Controls
Number of subjects: 75
Study: 11242488

Group type: EXPERIMENTAL
Intervention: Red pepper and caffeine
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control (no red pepper and caffeine)
Number of subjects: 8
Study: 9853772

Group type: EXPERIMENTAL
Intervention: Pregnancies complicated by HELLP syndrome
Number of subjects: 54
Study: 7503442

Group type: EXPERIMENTAL
Intervention: mannitol for 1 month
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: calcitonin intramuscularly for 1 month
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: programmed rehabilitation according to Mucha's scheme in 15 patients
Number of subjects: 60
Study: 3141343

Group type: EXPERIMENTAL
Intervention: Fleroxacin 400 mg
Number of subjects: 10

Group type: COMPARATOR
Intervention: Pefloxacin 400 mg
Number of subjects: 10
Study: 30341109

Group type: EXPERIMENTAL
Intervention: Arrabidaea chica herbal gel (2.5% standardised extract)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low-level laser therapy
Number of subjects: 0
Study: 28934783

Group type: EXPERIMENTAL
Intervention: Vertebral augmentation using a polyetheretherketone implant
Number of subjects: 144

Group type: COMPARATOR
Intervention: Balloon kyphoplasty (BK)
Number of subjects: 144
Study: 26312480

Group type: EXPERIMENTAL
Intervention: DPP treatments (specific treatments not detailed)
Number of subjects: 2553
Study: 22783981

Group type: EXPERIMENTAL
Intervention: Sodium arc bulb lamp used with 25% hydrogen peroxide
Number of subjects: 49

Group type: COMPARATOR
Intervention: 25% hydrogen peroxide without light
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Sensitivity recorded using a visual analogue scale
Number of subjects: 49
Study: 20828943

Group type: EXPERIMENTAL
Intervention: Disulfiram 62.5 mg/day
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Disulfiram 125 mg/day
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Disulfiram 250 mg/day
Number of subjects: 161

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 161
Study: 18443876

Group type: EXPERIMENTAL
Intervention: Magnetic resonance imaging (MRI)
Number of subjects: 55
Study: 14563578

Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Successful PCI
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Unsuccessful PCI
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: TIMI flow grade 3
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: TIMI flow grade 2
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: TIMI flow grade 0 or 1
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Severe mitral regurgitation
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Increasing age
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Lower systolic blood pressure
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Increasing time from randomization to PCI
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Lower post-PCI TIMI flow (0/1 vs. 2/3)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Multivessel PCI
Number of subjects: 82
Study: 10467834

Group type: EXPERIMENTAL
Intervention: C-reactive protein (CRP) estimation during treatment
Number of subjects: 201

Group type: COMPARATOR
Intervention: Control group (age-matched healthy children)
Number of subjects: 201
Study: 7883114

Group type: EXPERIMENTAL
Intervention: T-cell reactivity to beta-cell membrane preparation enriched for insulin-secretory granule antigen in newly diagnosed IDDM patients
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: T-cell reactivity in IDDM patients postonset
Number of subjects: 40

Group type: COMPARATOR
Intervention: T-cell reactivity in nondiabetic age-matched control subjects
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: T-cell reactivity in IDDM patients tested at least 2 years postonset
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: T-cell reactivity in children in remission for insulin dependency (honeymoon period)
Number of subjects: 40
Study: 2244447

Group type: EXPERIMENTAL
Intervention: Nitrous oxide (N2O) during halothane anaesthesia
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Nitrous oxide (N2O) during isoflurane anaesthesia
Number of subjects: 24

Group type: COMPARATOR
Intervention: Halothane anaesthesia without N2O
Number of subjects: 24

Group type: COMPARATOR
Intervention: Isoflurane anaesthesia without N2O
Number of subjects: 24
Study: 385093

Group type: EXPERIMENTAL
Intervention: Progesterone 200 mg b.d.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Progesterone 400 mg b.d.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31671432

Group type: EXPERIMENTAL
Intervention: Dupilumab 300 mg weekly
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 30777318

Group type: EXPERIMENTAL
Intervention: Transthoracic TAVI
Number of subjects: 191

Group type: COMPARATOR
Intervention: Transarterial TAVI
Number of subjects: 191
Study: 28338179

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.1 ug.kg‐1.min‐1)
Number of subjects: 124
Study: 25887253

Group type: COMPARATOR
Intervention: 2D laparoscopic radical prostatectomy (2D‐LERP)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: 3D laparoscopic radical prostatectomy (3D‐LERP)
Number of subjects: 86
Study: 23967738

Group type: EXPERIMENTAL
Intervention: ADV (10 mg/day, orally) plus peg‐IFN (180 microg/week, subcutaneous injection) for 48 weeks
Number of subjects: 65

Group type: COMPARATOR
Intervention: ADV plus LAM (100 mg/day, orally) for 48 weeks followed by continued LAM treatment for an additional 24 weeks
Number of subjects: 65
Study: 22086229

Group type: EXPERIMENTAL
Intervention: Intravesical gemcitabine 2,000 mg once per week for 6 weeks
Number of subjects: 14
Study: 19050051

Group type: EXPERIMENTAL
Intervention: KHCO3 (up to 90 mmol/d)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 17182200

Group type: EXPERIMENTAL
Intervention: Active acupuncture
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo acupuncture
Number of subjects: 29
Study: 15292935

Group type: EXPERIMENTAL
Intervention: CPT-11 and Nedaplatin (254-S)
Number of subjects: 27
Study: 11575342

Group type: EXPERIMENTAL
Intervention: Amrinone (5 microg kg(‐1) min(‐1) after a loading dose of 1.0 mg kg(‐1))
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (no amrinone)
Number of subjects: 20
Study: 10216371

Group type: EXPERIMENTAL
Intervention: Active forms of interstitial pulmonary diseases
Number of subjects: 170

Group type: COMPARATOR
Intervention: Control group (18 healthy persons)
Number of subjects: 170

Group type: COMPARATOR
Intervention: Inactive forms of interstitial pulmonary diseases
Number of subjects: 170
Study: 7889898

Group type: EXPERIMENTAL
Intervention: Fish oil (2.4 g n‐3 fatty acids)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Fish oil plus vitamin E (300 IU)
Number of subjects: 11

Group type: COMPARATOR
Intervention: No supplement
Number of subjects: 11
Study: 31755310

Group type: EXPERIMENTAL
Intervention: Adequate intake of cereals and grains (4-8 servings/day) among primary school children (54.7%)
Number of subjects: 2086

Group type: EXPERIMENTAL
Intervention: Adequate fruit consumption (2 servings/day)
Number of subjects: 2086

Group type: EXPERIMENTAL
Intervention: Adequate vegetable consumption (3 servings/day)
Number of subjects: 2086

Group type: EXPERIMENTAL
Intervention: Breakfast consumption frequency
Number of subjects: 2086

Group type: EXPERIMENTAL
Intervention: Bringing plain water to school
Number of subjects: 2086
Study: 29752345

Group type: EXPERIMENTAL
Intervention: Dual-hormone closed-loop system
Number of subjects: 20

Group type: COMPARATOR
Intervention: Single-hormone closed-loop system
Number of subjects: 20
Study: 26605514

Group type: EXPERIMENTAL
Intervention: TDF IVR
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo IVR
Number of subjects: 30
Study: 25219639

Group type: EXPERIMENTAL
Intervention: COM.TEC
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Trima
Number of subjects: 135

Group type: COMPARATOR
Intervention: All devices
Number of subjects: 135
Study: 22910287

Group type: EXPERIMENTAL
Intervention: ID3 (3 μg HA per strain)
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: ID9 (9 μg HA per strain)
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: INT9 (9 μg HA per strain)
Number of subjects: 262

Group type: COMPARATOR
Intervention: IM15 (15 μg HA per strain)
Number of subjects: 262
Study: 20630124

Group type: EXPERIMENTAL
Intervention: Exposure to media coverage or advertising about swine flu
Number of subjects: 1173

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 1173
Study: 19638143

Group type: EXPERIMENTAL
Intervention: Active (bupivicaine 0.75%)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham (normal saline)
Number of subjects: 20
Study: 16765453

Group type: EXPERIMENTAL
Intervention: Glatiramer acetate (GA)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 15039849

Group type: EXPERIMENTAL
Intervention: Decompressive craniectomy
Number of subjects: 5
Study: 10640975

Group type: EXPERIMENTAL
Intervention: Neoadjuvant androgen deprivation therapy (ADT) for 3 months followed by radical prostatectomy (RP)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Radical prostatectomy (RP) alone
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: PM2J004.5 anti-PSMA mAb
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: 7E11 anti-PSMA mAb
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: 7E11 and PM2J004.5 anti-PSMA mAbs
Number of subjects: 2
Study: 9291380

Group type: EXPERIMENTAL
Intervention: 1 unit (50 gram) of human polymerized hemoglobin (Poly SFH‐P)
Number of subjects: 39
Study: 8303906

Group type: EXPERIMENTAL
Intervention: Population screening for cardiovascular risk factors (hypertension, smoking, physical inactivity)
Number of subjects: 2073

Group type: EXPERIMENTAL
Intervention: Lipid values assessment
Number of subjects: 2073
Study: 3330031

Group type: EXPERIMENTAL
Intervention: Nitrendipine (5-20 mg b.d.)
Number of subjects: 275

Group type: EXPERIMENTAL
Intervention: Nitrendipine (subgroup of 11 patients)
Number of subjects: 275

Group type: COMPARATOR
Intervention: Propranolol (40-120 mg b.d.)
Number of subjects: 275

Group type: COMPARATOR
Intervention: Propranolol (subgroup of 11 patients)
Number of subjects: 275

Group type: EXPERIMENTAL
Intervention: Nitrendipine
Number of subjects: 275

Group type: COMPARATOR
Intervention: Propranolol
Number of subjects: 275
Study: 31365765

Group type: EXPERIMENTAL
Intervention: iGlarLixi (fixed-ratio combination of insulin glargine and lixisenatide)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: iGlarLixi
Number of subjects: 0

Group type: COMPARATOR
Intervention: Insulin glargine alone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lixisenatide alone
Number of subjects: 0
Study: 29705484

Group type: EXPERIMENTAL
Intervention: Cold therapy (ice packs for 20 minutes prior to chest tube removal)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Music therapy (listening to music for 30 minutes starting 15 minutes prior to chest tube removal)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Combination of cold and music therapy
Number of subjects: 180

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 180
Study: 26747258

Group type: EXPERIMENTAL
Intervention: True acupuncture (30 subjects)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Sham acupuncture (27 subjects)
Number of subjects: 57
Study: 24930478

Group type: EXPERIMENTAL
Intervention: Healthy Lifestyle Program (HeLP‐her Rural)
Number of subjects: 600

Group type: COMPARATOR
Intervention: Control towns (n=21)
Number of subjects: 600
Study: 22521235

Group type: EXPERIMENTAL
Intervention: Nasal irrigations with sulfurous‐arsenical‐ferruginous thermal water
Number of subjects: 70

Group type: COMPARATOR
Intervention: Isotonic sodium chloride solution
Number of subjects: 70
Study: 21189767

Group type: EXPERIMENTAL
Intervention: Gantrez‐NNP combination
Number of subjects: 2

Group type: COMPARATOR
Intervention: Conventional toothpaste
Number of subjects: 2
Study: 18729245

Group type: EXPERIMENTAL
Intervention: 500 mg/day EFLA943 for 8 weeks
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 1000 mg/day EFLA943 for 8 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (lifestyle advice)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Low-dose group (500 mg/day EFLA943)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: High-dose group (1000 mg/day EFLA943)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: All treatments
Number of subjects: 40